Sabby Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-142,000
| Closed | -$1.42M | – | 121 |
|
|
2021
Q3 | $1.42M | Buy |
142,000
+122,783
| +639% | +$1.23M | 0.19% | 36 |
|
|
2021
Q2 | $273K | Buy |
19,217
+9,967
| +108% | +$142K | 0.04% | 66 |
|
|
2021
Q1 | $152K | Buy |
+9,250
| New | +$152K | 0.03% | 75 |
|
|
2016
Q4 | – | Sell |
-38,100
| Closed | -$262K | – | 193 |
|
|
2016
Q3 | $262K | Buy |
+38,100
| New | +$262K | 0.01% | 118 |
|
|
2016
Q1 | – | Sell |
-90,000
| Closed | -$843K | – | 202 |
|
|
2015
Q4 | $843K | Sell |
90,000
-15,190
| -14% | -$142K | 0.05% | 90 |
|
|
2015
Q3 | $1.48M | Buy |
105,190
+5,190
| +5% | +$73K | 0.06% | 85 |
|
|
2015
Q2 | $2.1M | Buy |
+100,000
| New | +$2.1M | 0.08% | 57 |
|
|
2015
Q1 | – | Sell |
-98,951
| Closed | -$2.33K | – | 164 |
|
|
2014
Q4 | $2.33K | Sell |
98,951
-198,156
| -67% | -$4.66K | 0.07% | 43 |
|
|
2014
Q3 | $4.45K | Buy |
+297,107
| New | +$4.45K | 0.17% | 17 |
|